Date published: 2026-4-1

1-800-457-3801

SCBT Portrait Logo
Seach Input

TTYH2 Inhibitors

TTYH2 inhibitors are a class of chemical compounds designed to target and inhibit the activity of the Tweety homolog 2 (TTYH2) protein, which belongs to the Tweety family of chloride ion channels. TTYH2 is a transmembrane protein involved in the regulation of ion transport across the cell membrane, particularly chloride ions, which play a critical role in maintaining cellular homeostasis, osmotic balance, and signal transduction. TTYH2 is expressed in various tissues and is believed to participate in processes like cell volume regulation and chloride ion efflux. By inhibiting TTYH2, these compounds disrupt chloride ion flow, thereby altering the cellular ionic environment and influencing related physiological processes.

Structurally, TTYH2 inhibitors typically interact with specific regions of the protein, such as the transmembrane domains responsible for forming the ion-conducting pore. These inhibitors may block chloride ion binding or prevent the channel from opening, effectively reducing chloride transport across the membrane. By inhibiting TTYH2, researchers can gain insights into the protein's role in cellular ionic balance and its contribution to the regulation of various cellular activities such as signal transduction, cell proliferation, and volume regulation. TTYH2 inhibitors serve as valuable tools for investigating the mechanisms of chloride channel regulation and the broader implications of ion channel activity in cell physiology. Their use helps to elucidate the specific roles of TTYH2 in maintaining the delicate balance of ions that underpins many essential cellular functions.

SEE ALSO...

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Staurosporine

62996-74-1sc-3510
sc-3510A
sc-3510B
100 µg
1 mg
5 mg
$82.00
$153.00
$396.00
113
(4)

Inhibits protein kinases potentially regulating TTYH2 phosphorylation, altering its function.

BAPTA/AM

126150-97-8sc-202488
sc-202488A
25 mg
100 mg
$138.00
$458.00
61
(2)

Chelates calcium, leading to reduced calcium signaling that may affect TTYH2-dependent processes.

Genistein

446-72-0sc-3515
sc-3515A
sc-3515B
sc-3515C
sc-3515D
sc-3515E
sc-3515F
100 mg
500 mg
1 g
5 g
10 g
25 g
100 g
$45.00
$164.00
$200.00
$402.00
$575.00
$981.00
$2031.00
46
(1)

Inhibits tyrosine kinases which could modulate TTYH2 through tyrosine phosphorylation regulation.

W-7

61714-27-0sc-201501
sc-201501A
sc-201501B
50 mg
100 mg
1 g
$166.00
$306.00
$1675.00
18
(1)

Calmodulin antagonist that may alter TTYH2 function by disrupting calcium/calmodulin-dependent signaling.

PD 98059

167869-21-8sc-3532
sc-3532A
1 mg
5 mg
$40.00
$92.00
212
(2)

Inhibits MEK, which may affect TTYH2 activity by altering ERK/MAPK signaling pathways.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$123.00
$400.00
148
(1)

PI3K inhibitor, which may impact TTYH2 function by modulating the PI3K/AKT pathway.

2-Deoxy-D-glucose

154-17-6sc-202010
sc-202010A
1 g
5 g
$70.00
$215.00
26
(2)

Inhibits glycolysis, potentially affecting TTYH2 function by altering cellular energy levels.

Thapsigargin

67526-95-8sc-24017
sc-24017A
1 mg
5 mg
$136.00
$446.00
114
(2)

Disrupts calcium storage, potentially altering TTYH2 activity by modifying calcium homeostasis.

Tunicamycin

11089-65-9sc-3506A
sc-3506
5 mg
10 mg
$172.00
$305.00
66
(3)

Blocks N-linked glycosylation, potentially affecting TTYH2 function if it is glycosylation-dependent.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$63.00
$158.00
$326.00
233
(4)

mTOR inhibitor that may decrease TTYH2 synthesis or increase its degradation by affecting protein synthesis pathways.